Aarti Drugs Ltd

NSE: AARTIDRUGS · BSE: 524348 · Pharmaceuticals & Biotechnology · 30 announcements

Share price: ₹428.80
Market cap: ₹3,914 Cr
Revenue (annual): ₹2,565 Cr
Net profit (annual): ₹194.9 Cr
P/E (TTM): 20.5×Sector 47.4×
Promoter holding: 54.43%-0.60% QoQ
FII holding: 1.52%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Other Announcement 4 Legal & Regulatory 3 Board Meeting Date 3 Results Update 2 Management Change 2 Financial Results 2 Annual General Meeting 2 Share Pledge 1 Promoter Selling 1 Employee Stock Options 1 Board Meeting Outcome 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

27 Aug 2026 12:45 IST NSE

Employee Stock Options

Aarti Drugs Employee Stock Options

Aarti Drugs Limited board approved the Performance Stock Option Plan 2026. The plan involves granting up to 8,00,000 stock options to eligible employees, subject to shareholder approval.

Read the filing ↗